Evaluation and Management of Microscopic Hematuria

Introduction to Microscopic Hematuria

The American Family Physician recommends confirming true microscopic hematuria on repeat testing and assessing risk factors before referring a patient to urology for evaluation, as the finding of 3-5 RBCs/HPF meets the diagnostic threshold for microscopic hematuria 1, 2
The American Urological Association stratifies patients into risk categories that guide the evaluation approach, with high-risk features including age ≥60 years, smoking history >30 pack-years, occupational exposure to chemicals/dyes, history of gross hematuria, and history of urologic disorders 1, 2, 5

High-risk features that require full urologic evaluation after even one positive specimen include age ≥60 years, smoking history >30 pack-years, occupational exposure to chemicals/dyes, history of gross hematuria, and history of urologic disorders 1, 2, 5
Intermediate-risk features include women age 50-59 years or men age 40-59 years, smoking history 10-30 pack-years, and history of irritative voiding symptoms 1, 2, 5
Low-risk features include women <50 years or men <40 years, never smoker or <10 pack-years, and no additional risk factors 5

Refer to urology when confirmed microscopic hematuria (≥3 RBCs/HPF on 2 of 3 specimens) with non-glomerular features, any gross hematuria, or critical pitfalls to avoid such as anticoagulation or antiplatelet therapy 1, 4, 5
Refer to nephrology (or concurrent nephrology/urology referral) when glomerular features are present, including dysmorphic RBCs >80% on urinary sediment examination, red blood cell casts, significant proteinuria, elevated serum creatinine or declining renal function, or hypertension with hematuria and proteinuria 4, 5

Upper tract imaging: Multiphasic CT urography (preferred) to detect renal cell carcinoma, transitional cell carcinoma, and urolithiasis 4
Lower tract evaluation: Cystoscopy (mandatory for all patients ≥40 years) to evaluate for bladder tumors and carcinoma in situ 4
Laboratory testing: Serum creatinine, complete urinalysis with microscopy 4

If initial workup is negative but hematuria persists, repeat urinalysis at 6, 12, 24, and 36 months, monitor blood pressure at each visit, and consider comprehensive re-evaluation in 3-5 years if hematuria persists 4
Immediate re-evaluation is required if gross hematuria develops, significant increase in degree of microscopic hematuria, or new urologic symptoms appear 4, 5